Wedgewood Partners’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,675
Closed -$322K 39
2019
Q1
$322K Sell
4,675
-2,925
-38% -$196K 0.02% 35
2018
Q4
$453K Sell
7,600
-418,400
-98% -$36.1M 0.03% 28
2018
Q3
$49.3M Sell
426,000
-297,494
-41% -$33.6M 2.47% 19
2018
Q2
$91.3M Sell
723,494
-105,198
-13% -$12.8M 4.61% 12
2018
Q1
$89.7M Sell
828,692
-95,070
-10% -$10.5M 4.12% 13
2017
Q4
$101M Sell
923,762
-206,431
-18% -$20.6M 4.1% 14
2017
Q3
$112M Sell
1,130,193
-132,071
-10% -$12.8M 3.8% 15
2017
Q2
$128M Sell
1,262,264
-313,394
-20% -$33.8M 3.91% 13
2017
Q1
$182M Sell
1,575,658
-70,666
-4% -$8.21M 4.69% 10
2016
Q4
$198M Sell
1,646,324
-246,756
-13% -$27.3M 4.82% 8
2016
Q3
$213M Buy
1,893,080
+205,653
+12% +$23.7M 4.46% 12
2016
Q2
$209M Sell
1,687,427
-265,838
-14% -$32.1M 4.24% 14
2016
Q1
$220M Buy
1,953,265
+17,391
+0.9% +$1.81M 3.98% 16
2015
Q4
$211M Sell
1,935,874
-239,316
-11% -$27.4M 3.61% 17
2015
Q3
$217M Sell
2,175,190
-174,502
-7% -$19M 3.16% 16
2015
Q2
$268M Sell
2,349,692
-179,127
-7% -$21.7M 3.59% 15
2015
Q1
$264M Buy
2,528,819
+307,944
+14% +$32.8M 3.55% 14
2014
Q4
$267M Buy
+2,220,875
New +$292M 3.6% 13

Other funds holding CLB

Wedgewood Partners's CLB Position: Q2 2019 in Review

Wedgewood Partners sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 4,675 shares — an estimated $322K sold.

Wedgewood Partners first reported a position in CLB in Q4 2014 and held it in 18 quarters. The position peaked at $268M in Q2 2015. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

  • Wedgewood Partners reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
  • Wedgewood Partners sold 4,675 Core Laboratories shares in Q2 2019, an estimated $322K.
  • Wedgewood Partners first reported a position in Core Laboratories in Q4 2014 and held it in 18 quarters.
  • Wedgewood Partners's Core Laboratories position peaked at $268M in Q2 2015.
  • 304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Wedgewood Partners's 13F filing for Q2 2019, filed 14 Aug 2019.